Lanlin is the China CEO of Carcell Biopharma. She is a pharma and biotech veteran with more than 20 years of experience. Her previous roles include CEO of Dendron China, Assistant President of Sanpower Group, and Franchise Director at MSD (Merck & Co) China.
She has successfully managed cell therapy tech transfer, IND filing, and clinical trials in China. Her leadership experiences combine strategy, technology, commercial applications, and operations.